Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIPLETE RESET: Ticagrelor vs Prasugrel vs High-Dose Clopidogrel in PCI
NCT01543932Phase 3Completed
- Sponsor
- Sapienza University of Rome
- Start
- Jul 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor, prasugrel, clopidogrel in coronary artery disease (CAD), sponsored by Sapienza University of Rome. Started Jul 2012; status: completed.
02
Drugs
ticagrelorprasugrelclopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01543932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01543932.